Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Dejan Arzenšek

Scientist, DSP Development at LEK PHARMACEUTICALS D.D. part of Sandoz division as a NOVARTIS company

Profile

Currently Scientist at Downstream Process Development at LEK PHARMACEUTICALS D.D. part of Sandoz division as a NOVARTIS company and organizationally in Biologics Technical Development and Manufacturing (BTDM) Menges site.

PhD in Physics obtained at University of Ljubljana, Slovenia.

Expert in Process Analytical Technology (PAT) as part of Quality by Design (QbD) approach to drive protein drug process development towards Continuous Processing in Biopharmaceutical Manufacturing as part of nextBioPharmDSP project of EU Framework Programme for Research and Innovation “Horizon 2020”. Leading new technology project of PAT implementation on integrated processes using APC control strategies, where APC control system is building. Implementing and applying bioinformatics solutions (software, data integration) in order to find key technologies and methods and carrying out complex bioinformatics analyses. In the current department also an expert in drug substance ultrafiltration/diafiltration step.

Previously part of Protein Biophysics and Bioinformatics department.

Agenda Sessions